Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03935295 · ClinicalTrials.gov registry record · Phase 4

Dysport ® as an Adjunctive Treatment to Bracing in the Management of Adolescent Idiopathic Scoliosis

A Phase 4 study of Adolescent Idiopathic Scoliosis, sponsored by Johns Hopkins University.

Recruiting
Registry status
Phase 4
Development phase
90
Enrollment target
1
Study location

NCT03935295 is a Phase 4 study of Adolescent Idiopathic Scoliosis that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 90 participants, below the 265-participant average among 7 other Adolescent Idiopathic Scoliosis trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03935295, a Phase 4 study of Adolescent Idiopathic Scoliosis, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
Phase 4
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

This study evaluates the combined effect of botulinum toxin A (administered as Dysport® (Ipsen Pharmaceuticals)) and bracing in children with adolescent idiopathic scoliosis. Two thirds of patients will be treated with Dysport® and bracing, while the remaining patients will be treated with placebo and bracing.

Conditions Studied

Adolescent Idiopathic Scoliosis

Interventions

  • DRUG Placebos
  • DRUG AbobotulinumtoxinA
  • DEVICE Custom Thoracolumbosacral Orthosis

Study Locations (1)

Maryland

  • Johns Hopkins University - Baltimore

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2020-09-03
Est. Completion 2026-12-31
Phase Phase 4

Sponsor

Johns Hopkins University

1,448 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03935295

The ClinicalTrials.gov registry entry for NCT03935295 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 265-participant average among 7 other Adolescent Idiopathic Scoliosis trials with a reported enrollment target (66% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Adolescent Idiopathic Scoliosis appearing as the primary indexed condition, and to 3 interventions - of which Placebos is the first listed.

NCT03935295 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT03935295 about?

NCT03935295 is a clinical study titled "Dysport ® as an Adjunctive Treatment to Bracing in the Management of Adolescent Idiopathic Scoliosis". This study evaluates the combined effect of botulinum toxin A (administered as Dysport® (Ipsen Pharmaceuticals)) and bracing in children with adolescent idiopathic scoliosis. Two thirds of patients will be treated with Dysport® and bracing, while the remaining patients will be treated with placebo a...

What is the current status of trial NCT03935295?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 90 participants. The study started on 2020-09-03. Estimated completion is 2026-12-31.

What conditions does trial NCT03935295 study?

This clinical trial studies the following conditions: Adolescent Idiopathic Scoliosis.

What interventions are being tested in trial NCT03935295?

The interventions under investigation include: Placebos (DRUG), AbobotulinumtoxinA (DRUG), Custom Thoracolumbosacral Orthosis (DEVICE).

Who is sponsoring clinical trial NCT03935295?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03935295 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Adolescent Idiopathic Scoliosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Adolescent Idiopathic Scoliosis

All registered trials for this condition

Maryland

All trials with a study site in Maryland

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.